BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25366523)

  • 21. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impacts of You Gui Wan on the expression of estrogen receptors and angiogenic factors in OVX‑rat vagina: a possible mechanism for the trophic effect of the formula on OVX‑induced vaginal atrophy.
    Yin QZ; Lu H; Li LM; Yie SM; Hu X; Liu ZB; Zheng X; Cao S; Yao ZY
    Mol Med Rep; 2013 Nov; 8(5):1329-36. PubMed ID: 24009028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.
    Carter J; Baser RE; Goldfrank DJ; Seidel B; Milli L; Stabile C; Canty J; Saban S; Goldfarb S; Dickler MN; Gardner GJ; Jewell EL; Sonoda Y; Kollmeier MA; Alektiar KM
    Support Care Cancer; 2021 Jan; 29(1):311-322. PubMed ID: 32358778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The stimulation of the vaginal immune system with short-term administration of a vaginal gel containing fraction of Propionibacterium acnes, hyaluronic acid and polycarbophil is efficacious in vaginal infections dependent on disorders in the vaginal ecosystem.
    Melis GB; Piras B; Marotto MF; Neri M; Corda V; Vallerino V; Saba A; Lello S; Pilloni M; Zedda P; Paoletti AM; Mais V
    Gynecol Endocrinol; 2018 Oct; 34(10):880-883. PubMed ID: 29648469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.
    Al-Saqi SH; Uvnäs-Moberg K; Jonasson AF
    Post Reprod Health; 2015 Sep; 21(3):88-97. PubMed ID: 25995333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of topical oxytocin in improving vaginal atrophy in postmenopausal women: a randomized, controlled trial.
    Torky HA; Taha A; Marie H; El-Desouky E; Raslan O; Moussa AA; Ahmad AM; Abo-Louz A; Zaki S; Fares T; Eesa A
    Climacteric; 2018 Apr; 21(2):174-178. PubMed ID: 29347848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of prolonged-release hyaluronic acid derivative vaginal application in the postpartum period: a prospective randomised clinical trial.
    Gustavino C; Sala P; Cusini N; Gravina B; Ronzini C; Marcolin D; Vellone VG; Paudice M; Nappi R; Costantini S; Ferrero S; Barra F
    Ann Med; 2021 Dec; 53(1):1589-1597. PubMed ID: 34477473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.
    Crandall C
    J Womens Health (Larchmt); 2002 Dec; 11(10):857-77. PubMed ID: 12626086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of non-hormonal remedies for vaginal dryness: open, prospective, randomized trial.
    Stute P; May TW; Masur C; Schmidts-Winkler IM
    Climacteric; 2015; 18(4):582-9. PubMed ID: 25845406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled trial.
    Yaralizadeh M; Abedi P; Najar S; Namjoyan F; Saki A
    Maturitas; 2016 Feb; 84():75-80. PubMed ID: 26617271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy.
    Simon JA; Maamari RV
    Climacteric; 2013 Aug; 16 Suppl 1():37-43. PubMed ID: 23848490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical application of vitamin A reverses metaplasia of rat vaginal epithelium: a rapid and efficient approach to improve mucosal barrier function.
    Biesalski HK; Sobeck U; Weiser H
    Eur J Med Res; 2001 Sep; 6(9):391-8. PubMed ID: 11591530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaginal atrophy. Managing vaginal dryness and irritation.
    Mayo Clin Health Lett; 2012 Oct; 30(10):6. PubMed ID: 23133861
    [No Abstract]   [Full Text] [Related]  

  • 34. Oxytocin improves cytological and histological profiles of vaginal atrophy in postmenopausal women.
    Al-Saqi SH; Jonasson AF; Naessén T; Uvnäs-Moberg K
    Post Reprod Health; 2016 Mar; 22(1):25-33. PubMed ID: 26883689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women.
    Delgado JL; Estevez J; Radicioni M; Loprete L; Moscoso Del Prado J; Nieto Magro C
    Climacteric; 2016 Apr; 19(2):172-80. PubMed ID: 26786399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing postmenopausal vaginal atrophy. Vaginal dryness is one of the most irritating symptoms of menopause. Here are some ways to relieve it.
    Harv Womens Health Watch; 2010 Mar; 17(7):4-5. PubMed ID: 20480969
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaginal laser therapy versus hyaluronic acid suppositories for women with symptoms of urogenital atrophy after treatment for breast cancer: A randomized controlled trial.
    Gold D; Nicolay L; Avian A; Greimel E; Balic M; Pristauz-Telsnigg G; Tamussino K; Trutnovsky G
    Maturitas; 2023 Jan; 167():1-7. PubMed ID: 36279690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Martel C; Balser J
    Gynecol Endocrinol; 2010 Jul; 26(7):524-32. PubMed ID: 20459349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
    Ekin M; Yaşar L; Savan K; Temur M; Uhri M; Gencer I; Kıvanç E
    Arch Gynecol Obstet; 2011 Mar; 283(3):539-43. PubMed ID: 20135132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TCPL delivery system as a model for E + P replacement therapy in post-ovariectomized adult rats mimicking a postmenopausal condition.
    Cason Z; Benghuzzi H; Tucci M; England B
    Biomed Sci Instrum; 2003; 39():529-34. PubMed ID: 12724947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.